"10.1371_journal.pone.0079463","plos one","2013-11-15T00:00:00Z","Masahiro Kondo; Kunihiro Yamaoka; Koshiro Sonomoto; Shunsuke Fukuyo; Koichi Oshita; Yosuke Okada; Yoshiya Tanaka","The First Department of Internal Medicine, University of Occupational and Environmental Health, Yahatanishi-ku, Kitakyushu, Fukuoka, Japan; Pharmacology Research Laboratories I, Research Division, Mitsubishi Tanabe Pharma Corporation, Aoba-ku, Yokohama, Kanagawa, Japan","Conceived and designed the experiments: MK KY KS SF KO YO YT. Performed the experiments: MK. Analyzed the data: MK. Contributed reagents/materials/analysis tools: MK KY KS SF KO YO YT. Wrote the paper: MK KY YT.","Yoshiya Tanaka has read the journals policy and has the following conflicts: YT received consulting fees, lecture fees, and/or honoraria from Mitsubishi-Tanabe Pharma, Eisai, Chugai Pharma, Abbott Japan, Astellas Pharma, Daiichi-Sankyo, Abbvie, Janssen Pharma, Pfizer, Takeda Pharma, Astra-Zeneca, Eli Lilly Japan, GlaxoSmithKline, Quintiles, MSD, Asahi-Kasei Pharma, and received research grants from Bristol-Myers, Mitsubishi-Tanabe Pharma, Abbvie, MSD, Chugai Pharma, Astellas Pharma, Daiichi-Sankyo. MK and KO are employees of the Mitsubishi Tanabe Pharma Corporation. KY received consulting fees from Pfizer. The authors declare that there has been no significant financial support for this work which could have influenced its outcome, and this does not alter our adherence to all the PLOS ONE policies on sharing data and materials.","2013","11","Masahiro Kondo","MK",7,TRUE,7,1,1,3,TRUE,TRUE,FALSE,0,NA,FALSE
